Knabe, Ricarda; Muller, Philippe ORCID: 0009-0000-0985-7666; Schliemann, Christoph ORCID: 0000-0003-1755-9583; Hanoun, Maher ORCID: 0000-0002-1754-8940; Unglaub, Julia Marie ORCID: 0000-0002-3577-5493; Weinbergerová, Barbora ORCID: 0000-0001-6460-2471; Mayer, Jiri; Krekeler, Carolin ORCID: 0009-0000-1808-5928; Krause, Stefan W ORCID: 0000-0002-5259-4651; Kaufmann, Martin; Kraus, Sabrina ORCID: 0000-0001-8954-4220; Steffen, Björn; Modemann, Franziska ORCID: 0000-0002-5897-3310; Subklewe, Marion ORCID: 0000-0001-9154-9469; Bücklein, Veit L. ORCID: 0000-0001-7391-7280; Kunz, Wolfgang G. ORCID: 0000-0002-5021-1952; Rudelius, Martina ORCID: 0000-0001-6928-9955; von Bergwelt-Baildon, Michael ORCID: 0000-0002-1952-052X; Gutmair, Katja ORCID: 0009-0002-3948-6186; Hoster, Eva ORCID: 0000-0002-0749-1389; Herold, Tobias ORCID: 0000-0002-9615-9432; Röllig, Christoph ORCID: 0000-0002-3791-0548; Spiekermann, Karsten ORCID: 0000-0002-5139-4957 (2025): Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups. Blood Advances. ISSN 2473-9529

Mansour, Nabeel; Heinrich, Kathrin; Zhang, Danmei; Winkelmann, Michael; Ingenerf, Maria; Gold, Lukas; Klambauer, Konstantin; Rudelius, Martina; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Ricke, Jens; Heinemann, Volker; Westphalen, C. Benedikt; Kunz, Wolfgang G. (2024): Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation. Cancer Imaging, 24 (1). ISSN 1470-7330

Paul, Tanja; Ledderose, Stephan; Bartsch, Harald; Sun, Na; Soliman, Sarah; Märkl, Bruno; Ruf, Viktoria; Herms, Jochen; Stern, Marcel; Keppler, Oliver T.; Delbridge, Claire; Müller, Susanna; Piontek, Guido; Kimoto, Yuki Schneider; Schreiber, Franziska; Williams, Tracy Ann; Neumann, Jens; Knösel, Thomas; Schulz, Heiko; Spallek, Ria; Graw, Matthias; Kirchner, Thomas; Walch, Axel; Rudelius, Martina ORCID: 0000-0001-6928-9955 (2022): Adrenal tropism of SARS-CoV-2 and adrenal findings in a post-mortem case series of patients with severe fatal COVID-19. Nature Communications, 13: 1589. ISSN 2041-1723